Host–Microbe Interactions and Pathogenesis: Principles and Clinical Applications

Host–Microbe Interactions

Normal Microbiota and Their Roles

Normal microbiota are the diverse community of microorganisms that inhabit various regions of the human body, including the skin, digestive tract, genital, urinary, and respiratory systems. These microbes typically exist in a mutualistic or commensal relationship with the host, contributing to health and homeostasis.

• Mutualistic relationships: Microbes manufacture vitamins, compete with potential pathogens, and promote immune system maturation.

• Disruption of microbiota: Antibiotic therapy or illness can disturb the balance, leading to dysbiosis and increased susceptibility to opportunistic infections, such as Clostridium difficile overgrowth in the gut.

Opportunistic Pathogens

Opportunistic pathogens are typically harmless but can cause disease when the host's defenses are compromised or when they access unusual body sites.

• Normal microbiota vs. opportunistic pathogens: Both reside in or on the body; normal microbiota are usually beneficial or neutral, while opportunists cause disease under specific conditions (e.g., immune suppression, anatomical disruption).

• Example: Group B streptococci (GBS) are harmless in many women but can cause severe neonatal infections if transmitted during birth.

Host Factors and Pathogenicity

The outcome of host–microbe interactions depends on host factors such as immune status, anatomical barriers, and genetic predisposition. A microbe harmless in one individual may be pathogenic in another.

Pathogenesis and Virulence

Definitions and Concepts

• Pathogenicity: The ability of a microbe to cause disease (all-or-nothing concept).

• Virulence: The degree or severity of disease caused by a pathogen.

• Virulence factors: Molecules or structures that enable pathogens to colonize, invade, evade immune responses, and damage the host (e.g., toxins, adhesins, capsules).

• Attenuation: The process by which pathogens lose virulence factors and become less capable of causing disease, often used in vaccine development.

Infectious Dose and Lethal Dose

• Infectious dose-50 (ID50): The number of microbes required to infect 50% of exposed hosts. Lower ID50 indicates higher infectivity.

• Lethal dose-50 (LD50): The amount of toxin needed to kill 50% of affected hosts. Lower LD50 means higher toxicity.

Example: Botulinum toxin has a much lower LD50 than Salmonella toxin, making it more potent.

Portals of Entry

Pathogens enter the host through specific portals, which influence the infectious dose and disease manifestation.

• Skin (cutaneous): Entry via cuts, abrasions, or direct penetration.

• Respiratory tract: Most common portal; pathogens enter via inhalation of droplets or dust.

• Gastrointestinal tract: Entry via ingestion of contaminated food or water.

• Genitourinary tract: Entry via mucosal surfaces or direct invasion.

• Parenteral route: Entry via injections, bites, or wounds.

• Transplacental: Vertical transmission from mother to fetus.

Toxins and Their Effects

Endotoxins vs. Exotoxins

Toxins are microbial products that damage host tissues or disrupt normal physiology.

Property	Endotoxins	Exotoxins
Composition	Lipid (Lipid A of LPS)	Protein
Source	Gram-negative bacteria	Gram-positive and Gram-negative bacteria
Release	Upon cell death/division	Actively secreted
Fever	Yes	Sometimes
Neutralization	No	Yes (some)
Vaccines	No	Yes (some)
Toxicity	Lower (high LD50)	Higher (low LD50)

Endotoxins: Lipid A component of LPS in Gram-negative bacteria; released upon cell death, can cause septic shock.

Exotoxins: Secreted proteins with diverse targets and mechanisms; classified as neurotoxins, enterotoxins, etc.

Types of Exotoxins

• Type I: Bind to host cell membranes (e.g., superantigens).

• Type II: Disrupt host cell membranes (e.g., hemolysins).

• Type III: Enter host cells and disrupt intracellular functions (e.g., diphtheria toxin).

Fungal Toxins

• Ergot toxin: Produced by Claviceps purpurea, causes hallucinations.

• Aflatoxin: Produced by Aspergillus flavus, contaminates peanuts and is carcinogenic.

• Mycotoxins: Neurotoxins from mushrooms such as Amanita phalloides (death cap).

Steps of Infection

Five Steps to Infection

1. Entry into the host

2. Adherence to host tissues

3. Invasion and nutrient acquisition

4. Evasion of host immune defenses

5. Transmission to a new host

Adhesion Factors

Adhesins are molecules that enable pathogens to attach to host cells. These include fimbriae, pili, capsules, and specific membrane proteins.

Invasion and Nutrient Acquisition

Pathogens invade tissues using enzymes (invasins) and acquire nutrients through mechanisms such as siderophore production and extracellular enzyme secretion.

Invasin	Mechanism	Examples
Flagella	Motility, adhesion	E. coli, Vibrio vulnificus
Collagenases	Break down collagen	Clostridium perfringens
Neuraminidases	Break down neuraminic acid	Vibrio cholerae, Influenza virus
Coagulases	Promote blood clotting	Staphylococcus aureus
Kinases	Break down blood clots	Streptococcus pyogenes

Immune Evasion Strategies

Mechanisms for Escaping Host Immune Defenses

• Hiding: Intracellular lifestyle, antigen masking, mimicry, and variation, latency.

• Undermining: Suppressing immune function, avoiding phagocytosis, neutralizing immune factors.

Transmission and Exit

Portals of Exit

Pathogens exit the host via specific routes, often the same as their entry portals. Common portals include feces, urine, blood, respiratory droplets, and bodily fluids.

Biosafety and Infection Control

Biosafety Levels (BSL)

Biosafety levels are standardized protocols for handling infectious agents in laboratory and healthcare settings, ranging from BSL-1 (lowest risk) to BSL-4 (highest risk).

Level	PPE Required	Facility Considerations
BSL-1	None	Hand-washing sinks, open bench work
BSL-2	Lab coat, gloves, eye protection	Biohazard signage, restricted access, autoclave
BSL-3	Protective covering, gloves, respirators	Biological safety cabinets, controlled access, special airflow
BSL-4	Full-body suit, air supply	Specialized facility, highly restricted access

Infection Control Practices

• Standard precautions: Universal measures to prevent transmission of bloodborne and other pathogens (e.g., hand hygiene, gloves, barrier clothing, disinfection).

• Transmission precautions: Additional measures for known or suspected infectious agents, including contact, droplet, and airborne precautions.

Biofilms and Quorum Sensing

Biofilms are structured communities of microbes attached to surfaces, protected by an extracellular matrix. They are common sources of persistent infections, especially on medical devices and tissues.

• Examples: Catheters, prosthetic joints, dental plaque, kidney stones.

• Clinical significance: Biofilms are resistant to antibiotics and immune responses, complicating treatment.

Summary Table: Key Concepts

Concept	Definition/Example
Pathogenicity	Ability to cause disease
Virulence	Severity of disease
Virulence factors	Toxins, adhesins, enzymes, capsules
ID50	Infectious dose for 50% of hosts
LD50	Lethal dose for 50% of hosts
Biofilm	Microbial community on surfaces
BSL	Biosafety level for handling pathogens